Movement Alert｜Elevance Health Rises 3.07% in Pre-Market Trading, Technical Rebound After Q2 Sell-Off as Sector Recovers

Market Focus07-16 18:08

On July 16, Elevance Health rose 3.07% in pre-market trading, trading at approximately $402.15/share, with turnover of $98,500. The stock is rebounding after the prior session's 8.9% decline triggered by operating margin concerns following Q2 earnings.

Although Elevance Health reported Q2 adjusted EPS of $7.45, beating the consensus estimate of $6.21 by nearly 20%, and raised full-year adjusted EPS guidance to at least $27.00 versus the prior $26.75, the stock sold off sharply as operating margins compressed from 4.9% to 3.5% year-over-year. During the earnings call, management confirmed that federal Medicare agencies will not impose sanctions on its prescription drug plan, alleviating a key regulatory overhang. The CEO also disclosed plans to exit additional Medicaid markets over the next 12 to 18 months to optimize the business portfolio.

The broader managed healthcare sector is contributing to the rebound, with UnitedHealth up 6.33%, Humana up 5.46%, Molina Healthcare up 3.71%, and Centene up 3.56%, reflecting improved sector sentiment after the prior session's broad-based weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149384415?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 18:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149384415","market":"us","top_or_hot":-1,"title":"Movement Alert｜Elevance Health Rises 3.07% in Pre-Market Trading, Technical Rebound After Q2 Sell-Off as Sector Recovers","media":"Market Focus","content":"<p style=\"text-align: left;\">On July 16, Elevance Health rose 3.07% in pre-market trading, trading at approximately $402.15/share, with turnover of $98,500. The stock is rebounding after the prior session's 8.9% decline triggered by operating margin concerns following Q2 earnings.</p><p style=\"text-align: left;\">Although Elevance Health reported Q2 adjusted EPS of $7.45, beating the consensus estimate of $6.21 by nearly 20%, and raised full-year adjusted EPS guidance to at least $27.00 versus the prior $26.75, the stock sold off sharply as operating margins compressed from 4.9% to 3.5% year-over-year. During the earnings call, management confirmed that federal Medicare agencies will not impose sanctions on its prescription drug plan, alleviating a key regulatory overhang. The CEO also disclosed plans to exit additional Medicaid markets over the next 12 to 18 months to optimize the business portfolio.</p><p style=\"text-align: left;\">The broader managed healthcare sector is contributing to the rebound, with UnitedHealth up 6.33%, Humana up 5.46%, Molina Healthcare up 3.71%, and Centene up 3.56%, reflecting improved sector sentiment after the prior session's broad-based weakness.</p><p style=\"text-align: left;\">(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p><p style=\"text-align: left;\"></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Elevance Health Rises 3.07% in Pre-Market Trading, Technical Rebound After Q2 Sell-Off as Sector Recovers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Elevance Health Rises 3.07% in Pre-Market Trading, Technical Rebound After Q2 Sell-Off as Sector Recovers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-16 18:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p style=\"text-align: left;\">On July 16, Elevance Health rose 3.07% in pre-market trading, trading at approximately $402.15/share, with turnover of $98,500. The stock is rebounding after the prior session's 8.9% decline triggered by operating margin concerns following Q2 earnings.</p><p style=\"text-align: left;\">Although Elevance Health reported Q2 adjusted EPS of $7.45, beating the consensus estimate of $6.21 by nearly 20%, and raised full-year adjusted EPS guidance to at least $27.00 versus the prior $26.75, the stock sold off sharply as operating margins compressed from 4.9% to 3.5% year-over-year. During the earnings call, management confirmed that federal Medicare agencies will not impose sanctions on its prescription drug plan, alleviating a key regulatory overhang. The CEO also disclosed plans to exit additional Medicaid markets over the next 12 to 18 months to optimize the business portfolio.</p><p style=\"text-align: left;\">The broader managed healthcare sector is contributing to the rebound, with UnitedHealth up 6.33%, Humana up 5.46%, Molina Healthcare up 3.71%, and Centene up 3.56%, reflecting improved sector sentiment after the prior session's broad-based weakness.</p><p style=\"text-align: left;\">(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p><p style=\"text-align: left;\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV","symbol_name":"Elevance Health","start_time":0,"source_url":"","article_id":"1149384415","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149384415","pubTimestamp":1784196514,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 16, Elevance Health rose 3.07% in pre-market trading, trading at approximately $402.15/share, with turnover of $98,500. The stock is rebounding after the prior session's 8.9% decline...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ELV":"Elevance Health"},"translate_title":"走势警报|Elevance Health 在盘前交易中上涨 3.07%，随着行业复苏，第二季度抛售后技术反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1},"content_text":"On July 16, Elevance Health rose 3.07% in pre-market trading, trading at approximately $402.15/share, with turnover of $98,500. The stock is rebounding after the prior session's 8.9% decline triggered by operating margin concerns following Q2 earnings.Although Elevance Health reported Q2 adjusted EPS of $7.45, beating the consensus estimate of $6.21 by nearly 20%, and raised full-year adjusted EPS guidance to at least $27.00 versus the prior $26.75, the stock sold off sharply as operating margins compressed from 4.9% to 3.5% year-over-year. During the earnings call, management confirmed that federal Medicare agencies will not impose sanctions on its prescription drug plan, alleviating a key regulatory overhang. The CEO also disclosed plans to exit additional Medicaid markets over the next 12 to 18 months to optimize the business portfolio.The broader managed healthcare sector is contributing to the rebound, with UnitedHealth up 6.33%, Humana up 5.46%, Molina Healthcare up 3.71%, and Centene up 3.56%, reflecting improved sector sentiment after the prior session's broad-based weakness.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149384415","isCrawlerRequest":true}